**Question:** Led maternal serum a-FP is seen in:

**Core Concept:** Alpha-Fetoprotein (AFP) is a protein produced by the liver of the fetus and the yolk sac. In normal pregnancy, AFP levels in maternal serum decrease as fetal organogenesis progresses.

**Why the Correct Answer is Right:** Led maternal serum a-FP is typically seen in cases where there is an increase in the production of AFP in the fetus, such as in certain congenital anomalies or diseases.

**Why Each Wrong Option is Incorrect:**

A. Normal: AFP levels decrease as fetal organogenesis progresses.
B. Neural Tube Defects (NTDs): Although AFP levels may be elevated, the correct answer should specifically mention led maternal serum a-FP.
C. Increased Resorption: This refers to the process of fetus death, not increased AFP production.
D. Liver Disease: While liver disease can increase AFP levels, the correct answer should focus on led maternal serum a-FP.

**Clinical Pearl / High-Yield Fact:** Led maternal serum AFP is a clinical indicator of increased fetal production of AFP, such as in certain congenital anomalies like open neural tube defects (e.g., spina bifida). Monitoring AFP levels is an important tool for prenatal diagnosis and surveillance of fetal anomalies.

**Correct Answer:** D. Increased Resorption (led maternal serum a-FP)

Explanation: Led maternal serum alpha-fetoprotein (AFP) is a marker for increased fetal production of AFP, which may occur due to various reasons like increased resorption (death of fetus) or congenital anomalies. Among the given options, option D ("Increased Resorption") is the correct answer as it specifically mentions led maternal serum AFP, which refers to increased fetal AFP production, often seen in cases of fetal resorption (death). Other options are not relevant to led maternal serum AFP and do not address the increased AFP production.